Ankylosing Spondylitis, Gene Expression, HLA-B27, and the GS145.2 Antibody
Gene expression is the fundamental biological process through which cells interpret the information encoded in DNA to produce functional molecules, primarily proteins. These proteins perform the essential tasks that allow cells and tissues to function. In practical terms, gene expression acts like a regulatory system—similar to an on/off switch or volume control—ensuring that the right genes are active in the right cells at the right time.
Although every cell in the human body contains essentially the same genetic blueprint, different cell types activate different sets of genes. For example, pancreatic beta cells express the gene responsible for producing insulin, whereas lung epithelial cells do not. This selective expression enables cellular specialization and is tightly controlled by multiple regulatory mechanisms.
Some people with inflammatory conditions such as ankylosing spondylitis may have increased sensitivity to certain foods, cold temperatures, and physical movements. Cold weather can worsen joint stiffness and pain, while certain foods may trigger inflammation in sensitive individuals. Sudden or repetitive movements can also irritate inflamed joints and connective tissues, potentially leading to increased discomfort or flare-ups.
Core Steps in Gene Expression
Gene expression occurs through two primary steps: transcription and translation, with additional layers of regulation.
Transcription
During transcription, a specific segment of DNA corresponding to a gene is copied into messenger RNA (mRNA) within the cell nucleus. This process is carried out by enzymes known as RNA polymerases. The resulting mRNA molecule contains a sequence that reflects the genetic instructions stored in the DNA.
Translation
After transcription, the mRNA molecule travels from the nucleus into the cytoplasm. There, ribosomes read the mRNA sequence and translate it into a chain of amino acids. This amino acid chain then folds into a functional protein that carries out a particular biological function.
Regulation
Cells carefully regulate gene expression to control how much protein is produced and when it is produced. Regulatory proteins called transcription factors can activate or suppress specific genes, allowing cells to respond to environmental signals, developmental cues, or immune responses.
Gene expression also plays a critical role in disease mechanisms and medical diagnostics. One important example involves the expression of specific immune system proteins known as human leukocyte antigens.
HLA-B27 and Its Clinical Importance
HLA-B27 is a protein belonging to the human leukocyte antigen (HLA) class I family, which is part of the major histocompatibility complex (MHC). These molecules are expressed on the surface of most nucleated cells and help the immune system distinguish between the body’s own cells and foreign invaders such as viruses or bacteria.
HLA-B27 expression can be detected using laboratory techniques that measure proteins on the surface of immune cells.
GS145.2 Antibody in Clinical Diagnostics
One widely used laboratory reagent for detecting HLA-B27 expression is the GS145.2 antibody. GS145.2 is a monoclonal antibody clone commonly used in flow cytometry assays to identify the HLA-B27 antigen on the surface of white blood cells.
In a flow cytometry test, blood cells are labeled with fluorescent antibodies that bind to specific surface proteins. When the GS145.2 antibody binds to HLA-B27 molecules, the fluorescent signal allows laboratory instruments to detect and quantify the presence of this antigen.
Purpose of the GS145.2 Antibody
The primary diagnostic purpose of the GS145.2 antibody is to identify individuals who express the HLA-B27 antigen. This information is clinically useful because HLA-B27 is strongly associated with ankylosing spondylitis and related inflammatory conditions.
Cross-Reactivity
A limitation of the GS145.2 antibody is that it may cross-react with other HLA-B antigens, particularly HLA-B7 and certain related variants. Cross-reactivity means that the antibody may bind to similar proteins that are not actually HLA-B27, potentially producing false-positive test results.
Gray-Zone Results and Genetic Confirmation
When flow cytometry results are ambiguous or fall into a diagnostic “gray zone,” clinicians often recommend confirmatory genetic testing. Molecular genotyping directly examines the patient’s DNA to determine whether the HLA-B27 gene is present. This approach provides a more definitive result than protein-based detection alone.
Ankylosing Spondylitis: Overview
Ankylosing spondylitis (AS) is a chronic inflammatory form of arthritis that primarily affects the spine and sacroiliac joints, which connect the lower spine to the pelvis. Over time, persistent inflammation can lead to structural damage, reduced spinal flexibility, and in severe cases, fusion of the vertebrae.
The disease most commonly begins in early adulthood and progresses gradually. One of its defining features is inflammatory back pain that worsens during periods of rest and improves with physical activity.
Key Symptoms of Ankylosing Spondylitis
The symptoms of ankylosing spondylitis can vary in severity and often occur in cycles of flares and remission. Common symptoms include:
Chronic Back Pain and Stiffness
Persistent pain in the lower back, buttocks, or hips lasting more than three months. The discomfort is often worst in the early morning or during the night and may wake a person from sleep.
Improvement with Activity
Unlike mechanical back pain, the symptoms of ankylosing spondylitis frequently improve with exercise or movement and worsen during prolonged inactivity.
Progressive Spinal Stiffness
Ongoing inflammation can gradually reduce spinal flexibility. In advanced cases, the spine may become rigid and develop a forward-curving posture.
Enthesitis
Inflammation can occur where tendons and ligaments attach to bone. This may cause pain in areas such as the heels (Achilles tendon), ribs, or elbows.
Fatigue
Persistent inflammation can lead to severe fatigue that does not improve with rest.
Peripheral Joint Involvement
Although the spine is primarily affected, joints such as the hips, shoulders, knees, or feet may also become inflamed.
Reduced Chest Expansion
Inflammation involving the rib joints may limit chest movement, making deep breathing difficult.
Eye Inflammation (Uveitis or Iritis)
Approximately 25–35 percent of individuals with ankylosing spondylitis develop episodes of eye inflammation characterized by redness, pain, light sensitivity, and blurred vision.
Systemic Symptoms
Some individuals experience additional symptoms such as mild fever, unexplained weight loss, anemia, digestive discomfort, or skin manifestations.
Because ankylosing spondylitis is a systemic inflammatory disease, it can affect multiple organ systems, including the cardiovascular system.
Diagnosis of Ankylosing Spondylitis
There is no single test that definitively diagnoses ankylosing spondylitis. Physicians typically rely on a combination of clinical symptoms, imaging studies, laboratory tests, and physical examination findings.
Imaging Studies
Imaging is one of the most important components of diagnosis.
X-rays can reveal structural changes in the sacroiliac joints, such as joint erosion, sclerosis, or fusion. However, these changes may take years to become visible.
Magnetic resonance imaging (MRI) is more sensitive and can detect early inflammatory changes before permanent structural damage occurs.
Blood Tests
Blood tests may support the diagnosis by identifying markers of inflammation or genetic susceptibility.
Testing for the HLA-B27 gene helps determine whether the genetic marker associated with ankylosing spondylitis is present.
Inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) measure the level of systemic inflammation in the body.
Physical Examination
Doctors also assess spinal mobility and chest expansion.
The Modified Schober’s Test measures flexibility in the lower spine by assessing how far the lumbar region can stretch during forward bending.
Chest expansion measurements evaluate whether inflammation has restricted rib movement.
Treatment Strategies
Although there is currently no cure for ankylosing spondylitis, several treatments can effectively reduce symptoms, control inflammation, and slow disease progression.
Physical Therapy and Exercise
Regular exercise is a cornerstone of treatment. Stretching and strengthening exercises help maintain spinal mobility, improve posture, and reduce stiffness. Hydrotherapy, which involves exercise in warm water, is often recommended because it allows gentle movement with minimal joint strain.
Medications
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen are typically the first-line medications used to control pain and inflammation.
Biologic medications are often prescribed when NSAIDs are insufficient. These include tumor necrosis factor (TNF-alpha) inhibitors such as adalimumab and etanercept, and interleukin-17 (IL-17) inhibitors such as secukinumab. These drugs target specific immune pathways responsible for inflammation.
Janus kinase (JAK) inhibitors, such as upadacitinib, represent a newer class of targeted therapy used in some severe cases.
Disease-modifying antirheumatic drugs (DMARDs), including sulfasalazine, may be helpful for peripheral joint involvement, though they are less effective for spinal inflammation.
Corticosteroids are sometimes injected directly into severely inflamed joints but are rarely used as long-term systemic therapy.
Lifestyle and Self-Care
Lifestyle choices can significantly influence disease progression and symptom severity. Maintaining good posture, engaging in daily exercise, and following a balanced diet support overall health.
Smoking cessation is particularly important because smoking has been associated with more severe disease progression.
Surgical Intervention
Surgery is rarely required but may be necessary in cases of severe hip joint damage or extreme spinal deformity that interferes with daily function.
Conclusion
Ankylosing spondylitis is a complex inflammatory disease involving genetic predisposition, immune system dysregulation, and chronic inflammation of the spine and joints. The HLA-B27 antigen plays a major role in disease susceptibility, and its detection through laboratory techniques such as flow cytometry using the GS145.2 antibody provides valuable diagnostic information.
Understanding gene expression, immune markers like HLA-B27, and the tools used to detect them helps clinicians identify at-risk individuals and guide diagnostic decisions. While ankylosing spondylitis remains a lifelong condition, advances in imaging, molecular diagnostics, and targeted therapies have significantly improved the ability to manage symptoms and maintain quality of life.
References:
Ankylosing
spondylitis (AS) is a type of arthritis that affects the joints in your spine
https://my.clevelandclinic.org/health/diseases/ankylosing-spondylitis
Overview Ankylosing spondylitis https://www.nhs.uk/conditions/ankylosing-spondylitis/
Diagnosis
- Ankylosing spondylitis
https://www.nhs.uk/conditions/ankylosing-spondylitis/diagnosis/
Ankylosing spondylitis - specialists and information on ankylosing spondylitis https://www.leading-medicine-guide.com/en/illness/muscles-bones/ankylosing-spondylitis-as
© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9
Comments
Post a Comment